Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105820061A details a green N-alkylamide synthesis using nitriles. Discover cost reduction in pharma intermediate manufacturing and scalable supply solutions.
Patent CN111574487A details asymmetric hydrogenation for chiral dihydroisoflavones. Offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Patent CN1468852A reveals a breakthrough iridium-catalyzed method for asymmetric hydrogenation of aromatic heterocycles, offering high ee and scalable manufacturing for API intermediates.
Patent CN113166183B reveals a novel iridium process for high-purity hydroxylamine synthesis, offering significant cost reduction and supply chain reliability for complex intermediates.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN102167674A details a mild iridium-catalyzed method for synthesizing optically pure 3-aryl sulfur-substituted propenes, offering significant supply chain advantages.
Patent CN109956946B details a novel iridium-catalyzed method for synthesizing chiral amines with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Patent CN113354554B details an efficient Iridium-catalyzed asymmetric hydrogenation route for carbapenem intermediates, offering superior stereoselectivity and scalable manufacturing capabilities.
Patent CN104854071B details asymmetric hydrogenation for high-purity tocopherol precursors. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN112047865B details a green aqueous synthesis of N-alkylsulfonamides using Cp*Ir catalysts, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN1139576C details a novel iridium-catalyzed asymmetric hydrogenation process for producing high-purity dextromethorphan intermediates with enhanced supply chain reliability.
Patent CN102675168A details a high-ee iridium-catalyzed allylation method for chiral thioethers, offering superior regioselectivity and mild conditions for API intermediates.
Patent CN110668976A reveals a novel Ir-catalyzed asymmetric synthesis for (R)-Rivastigmine intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.
Patent CN112876401A discloses a mild, one-step iridium-catalyzed synthesis of chiral 3-allylindoles with high enantioselectivity, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN119431242A reveals Ir-catalyzed cycloaddition for high-purity intermediates. Enables cost reduction and scalable supply for global drug development.
Patent CN114085219A details a high-ee synthesis of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane. This route offers superior yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN105712854B reveals efficient Ir-catalyzed biomass conversion. Achieve high purity and cost reduction in fine chemical manufacturing with scalable aqueous processes.
Patent CN102924360A reveals efficient asymmetric hydrogenation for chiral indolinones. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.